When the Netherlands’ most influential science advisory body visits your ecosystem, it is not a coincidence.
Today, the Scientific Council for Government Policy (WRR – Netherlands Scientific Council for Government Policy) brought its full council to Leiden Bio Science Park, 15 members gathering input for an advisory report that will help shape Dutch policy on biotech and life sciences toward 2050.
The questions on the table matter:
- How do public-private partnerships actually work in practice?
- Where do they break down? What infrastructure does Europe need to remain competitive as the US and China accelerate investment?
- And what does it take to keep a top-five cluster operating at the level the sector demands?
These are not abstract questions here. The park houses 500+ organisations spanning the full value chain, from fundamental research at Leiden Univiersity and Leiden University Medical Center to clinical development, manufacturing, and commercial scale. The BioTech Training Facility one of only six of its kind worldwide, operates from this site. Shared infrastructure of this kind takes decades to build and requires sustained investment to maintain.
One message runs through every conversation we have with policymakers: Europe needs to choose. Not a thousand flowers, but a committed investment in the clusters that already have the depth, the track record, and the international pull to compete. Leiden Bio Science Park is one of them.
The WRR’s visit is part of a broader national conversation, one that started with the Wennink Report and the red biotech growth strategy developed by this sector, and continues as the Netherlands works out what it actually means to designate life sciences as a strategic priority. Succeeding requires clearing the obstacles that slow progress across the entire chain, from early discovery through clinical development to getting new treatments to patients. Designation is the beginning, not the outcome.
The work of translating political intent into funded, functioning infrastructure is what comes next.
Thank you for your hospitality Johnson & Johnson Innovation Medicine, TNO, and BioTech Training Facility.
Thank you Leyden Labs and VarmX for the tour.
